Use of a Wearable Biosensor to Study Heart Rate Variability in Chronic Obstructive Pulmonary Disease and Its Relationship to Disease Severity

Abstract

a p (r We by in no of to HF, HRV R-R The all and low the via was BODE COPD SDNN Test When also high mean rate than that this were with (CAT) (HF), (HRV) (LF), (beta LF/HF SDNN, Saint There after class heart index lower other ratio score study using (SGRQ) (VSAQ) (mMRC) 0.006) 0.285, 0.308, health normal ratio. relate status (COPD), -0.234, -0.269, -0.280, -0.298, -3.980, 0.008), 0.011), 0.012), 0.019). 0.020). 0.039), Council Medical agonist between chronic device, disease dyspnea explore inhaled patient purpose reduced therapy treated various Activity George's Research Specific Veterans analysis handgrip measured measures modified observed reported strength symptoms wearable (standard according adjusting biosensor deviation enrolled. evaluated frequency measures. outcomes. patients. performed pulmonary receiving secondly, severity, severity. Assessment chest-worn concurrent correlated functional muscarinic negatively phenotypic positively Respiratory antagonists coefficient demonstrate differences feasibility intervals), obstructive performance prescribed, variability Seventy-nine antagonists. ascertaining associations participants Questionnaire beta-agonists questionnaire relationships bronchodilator beta-sympathomimetic